| Literature DB >> 33191093 |
Hao-Yuan Cheng1, Yu-Neng Chueh1, Chiu-Mei Chen1, Shu-Wan Jian1, Shu-Kuan Lai1, Ding-Ping Liu2.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has become severe threats to economic, societal, and healthcare systems. To analyze the epidemiological characteristics of the COVID-19 outbreak in Taiwan and evaluate the key interventions, we conducted a retrospective cohort study during January 17-June 30, 2020. As of June 30, the COVID-19 outbreak, including 447 laboratory-confirmed cases, was eliminated by mixed approaches: border control, enhanced surveillance, case detection with contact tracing, quarantine, and population-based interventions like face mask use. The improvement of median time from disease onset to notification (5 days [range -3 to 27] before March 1 to 1 day [range -8 to 22] after March 1) suggested the timeliness and comprehensiveness of surveillance and contact tracing. Travel restrictions with quarantine, resulting in fewer clusters, were also complementary to minimize disease spread. Under combined interventions, Taiwan successfully contained the COVID-19 spread within the country and minimized its impact on the society.Entities:
Keywords: COVID-19; Outbreak; Quarantine; SARS-CoV-2; Surveillance
Year: 2020 PMID: 33191093 PMCID: PMC7605820 DOI: 10.1016/j.jfma.2020.10.023
Source DB: PubMed Journal: J Formos Med Assoc ISSN: 0929-6646 Impact factor: 3.282
Figure 1Daily number of confirmed COVID-19 cases by date of onset — Taiwan, January 17–June 30, 2020 (n = 421). Twenty-six asymptomatic cases were not included. COVID-19, coronavirus disease 2019; travel hx, travel history. §The case definition, especially the epidemiological criteria, evolved corresponding to the progress of the COVID-19 pandemic and epidemic situation in Taiwan. The list of level 1 and level 2 epidemic areas were adjusted according to the risk of exporting COVID-19 cases to Taiwan. Level 1 epidemic areas included Hubei (from January 25, 2020), Guangdong (February 8), Henan and Zhejiang (February 15); level 2 epidemic areas included Guangdong (February 2), Zhejiang (February 5), and the whole mainland China (February 6).
Demographic and clinical characteristics of confirmed COVID-19 patients — Taiwan, January 17–June 30, 2020 (N = 447).
| Total | 1st stage | 2nd stage | Naval crew members | |
|---|---|---|---|---|
| 447 (100) | 46 (10.3) | 365 (81.7) | 36 (8.0) | |
| 31 (4–88) | 52 (11–88) | 31 (4–80) | 24.5 (21–41) | |
| Male | 223 (49.9) | 18 (39.1) | 173 (47.4) | 32 (88.9) |
| Female | 224 (50.1) | 28 (60.9) | 192 (52.6) | 4 (11.1) |
| Imported | 356 (86.6) | 20 (43.5) | 336 (92.1) | |
| Locally-acquired | 55 (13.4) | 26 (56.5) | 29 (7.9) | |
| Yes | 103 (23.0) | 24 (52.2) | 72 (19.7) | 7 (19.4) |
| No | 341 (76.3) | 22 (47.8) | 290 (79.5) | 29 (80.5) |
| Unknown | 3 (0.7) | 0 (0) | 3 (0.8) | 0 (0) |
| Mild illness/Asymptomatic | 308 (68.9) | 23 (50.0) | 252 (69.0) | 33 (91.7) |
| Mild pneumonia | 101 (22.6) | 17 (37.0) | 81 (22.2) | 3 (8.3) |
| Severe pneumonia or ARDS | 38 (8.5) | 6 (13.0) | 32 (8.8) | 0 (0) |
| 7 (1.6) | 3 (6.5) | 4 (1.1) | 0 (0) | |
| 1 (−8 to 27) | 5 (−3 to 27) | 1 (−8 to 22) | ||
| 24 (−1 to 79) | 26 (−1 to 79) | 24 (5–74) | 22 (7–48) | |
Values are no. (%) except as indicated. COVID-19, coronavirus disease 2019.
Outbreak stages were classified according to the global epidemic situation. In the first stage (January 17–February 29, 2020), COVID-19 cases were more likely linked to China or locally-acquired cases. In the second stage (March 1–June 30), cases were majorly imported from European countries or U.S. due to the global pandemic. An outbreak among naval crew members was excluded from the group of second stage because of its different characteristics.
Information retrieved from preliminary case investigation.
Some cases were tested positive for SARS-CoV-2 as asymptomatic cases and developed symptoms during isolation.
One case was confirmed after death.